Of baseball and enhancement bondage
By Pete Shanks,
San Francisco Chronicle
| 09. 26. 2005
Baseball fans around the nation have been conducting their own straw poll about human enhancement, and they don't like it. Rafael Palmeiro has practically been driven out of the game, Mark McGwire is now seen as more cartoon than hero, and Jason Giambi is treated with widespread derision.
Then there is Barry Bonds.
Bonds is -- as usual -- a lightning rod for everyone's feelings, a walking paradox who illustrates without even trying just how complex these issues are. He told reporters before his first game in Washington, D.C., that there are more serious issues than steroids, but all that did was increase the hype about his appearance. And he lived up to it.
Bonds getting booed is not unusual in a road game. But in Washington, he was booed by fans who were on their feet as he homered to the upper deck -- clapping at the same time they were jeering. Whether they were right or wrong about Bonds (who denies ever knowingly taking illegal substances), there couldn't be a more dramatic illustration of the conflicts we feel...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...